Seshu Tyagarajan, Ph.D., RAC
2022
In 2022, Seshu Tyagarajan, Ph.D., RAC earned a total compensation of $916K as Chief Technical and Development Officer at Candel Therapeutics.
Compensation breakdown
| Bonus | $20,000 |
|---|---|
| Non-Equity Incentive Plan | $73,238 |
| Option Awards | $454,752 |
| Salary | $235,385 |
| Stock Awards | $126,000 |
| Other | $6,646 |
| Total | $916,020 |
RAC received $454.8K in option awards, accounting for 50% of the total pay in 2022.
RAC also received $20K in bonus, $73.2K in non-equity incentive plan, $235.4K in salary, $126K in stock awards and $6.6K in other compensation.
Rankings
In 2022, Seshu Tyagarajan, Ph.D., RAC's compensation ranked 3,221st out of 5,736 executives tracked by ExecPay. In other words, RAC earned more than 43.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,221 out of 5,736 | 44th |
Division Manufacturing | 1,813 out of 3,125 | 42nd |
Major group Chemicals And Allied Products | 863 out of 1,416 | 39th |
Industry group Drugs | 807 out of 1,317 | 39th |
Industry Biological Products, Except Diagnostic Substances | 192 out of 291 | 34th |
Source: SEC filing on May 23, 2023.
RAC's colleagues
We found two more compensation records of executives who worked with Seshu Tyagarajan, Ph.D., RAC at Candel Therapeutics in 2022.